Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SCMP

(SCMP) (SCMP) Stock Price, News & Analysis

(SCMP) logo

About (SCMP) Stock (NASDAQ:SCMP)

Key Stats

Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$9.30
$18.75
Volume
303,068 shs
Average Volume
2.56 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).

Receive SCMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SCMP) and its competitors with MarketBeat's FREE daily newsletter.

SCMP Stock News Headlines

Mysterious drone activity triggers massive 1,366% surge
If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.
See More Headlines

SCMP Stock Analysis - Frequently Asked Questions

(SCMP) (NASDAQ:SCMP) posted its quarterly earnings data on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.02. The business's revenue was up 5.9% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (SCMP) investors own include XOMA (XOMA), Sprint (SPRINT), Micron Technology (MU), SandRidge Energy (SD), AT&T (T), Vale (VALE) and Cisco Systems (CSCO).

Company Calendar

Last Earnings
11/01/2017
Today
12/25/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SCMP
CUSIP
86490910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NASDAQ:SCMP) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners